Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0338.HK Stock Summary
Top 10 Correlated ETFs
0338.HK
In the News
0338.HK Financial details
Company Rating
Neutral
Market Cap
25.33B
Income
-1.41B
Revenue
99.29B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
8.01K
Optionable
No
Shortable
Yes
Earnings
22 Aug 2024
P/E
0
Forward P/E
-
PEG
-
P/S
0.39
P/B
-
P/C
-
P/FCF
-6.6
Quick Ratio
0.71
Current Ratio
1.16
Debt / Equity
0.15
LT Debt / Equity
0
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
1.1%
Revenue Q/Q
-25.78%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-6%
ROE
-8%
ROC
-0.11%
Gross Margin
14%
Oper. Margin
-4%
Profit Margin
-3%
Payout
-5%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.99-1.43
52W High
-
52W Low
-
RSI
45
Rel Volume
1.11
Avg Volume
9.06M
Volume
10.04M
Perf Week
-0.94%
Perf Month
-5.41%
Perf Quarter
2.94%
Perf Half Y
-0.94%
-
-
-
-
Beta
0.795
-
-
Volatility
0.02%, 0.04%
Prev Close
1.94%
Price
1.05
Change
2.94%
0338.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.14 | 5.69 | 7.01 | 6.72 | 0 | |
Net income per share | 0.2 | 0.06 | 0.18 | -0.26 | 0 | |
Operating cash flow per share | 0.47 | 0.16 | 0.36 | -0.69 | 0 | |
Free cash flow per share | 0.34 | -0.01 | 0.07 | -0.95 | 0 | |
Cash per share | 1.28 | 1.12 | 1.25 | 0.42 | 0 | |
Book value per share | 2.76 | 2.7 | 2.79 | 2.42 | 0 | |
Tangible book value per share | 2.74 | 2.67 | 2.77 | 2.4 | 0 | |
Share holders equity per share | 2.76 | 2.7 | 2.79 | 2.42 | 0 | |
Interest debt per share | 0.15 | 0.43 | 0.22 | 0.22 | 0 | |
Market cap | 22.71B | 15.03B | 15.81B | 12.61B | 0 | |
Enterprise value | 16.83B | 12.69B | 12.97B | 13.99B | -1.9B | |
P/E ratio | 10.25 | 23.93 | 7.9 | -4.44 | 0 | |
Price to sales ratio | 0.26 | 0.24 | 0.21 | 0.17 | 0 | |
POCF ratio | 4.49 | 8.95 | 4 | -1.69 | 0 | |
PFCF ratio | 6.26 | -93.27 | 21.78 | -1.22 | 0 | |
P/B Ratio | 0.76 | 0.51 | 0.52 | 0.48 | 0 | |
PTB ratio | 0.76 | 0.51 | 0.52 | 0.48 | 0 | |
EV to sales | 0.19 | 0.21 | 0.17 | 0.19 | -0.02 | |
Enterprise value over EBITDA | 3.86 | 22.31 | 2.79 | -4.03 | -3.1 | |
EV to operating cash flow | 3.33 | 7.55 | 3.28 | -1.88 | -2.35 | |
EV to free cash flow | 4.64 | -78.76 | 17.86 | -1.36 | 2.35 | |
Earnings yield | 0.1 | 0.04 | 0.13 | -0.23 | 0 | |
Free cash flow yield | 0.16 | -0.01 | 0.05 | -0.82 | 0 | |
Debt to equity | 0.05 | 0.16 | 0.07 | 0.09 | 0.15 | |
Debt to assets | 0.03 | 0.1 | 0.05 | 0.06 | 0.09 | |
Net debt to EBITDA | -1.35 | -4.11 | -0.61 | -0.4 | -3.1 | |
Current ratio | 1.44 | 1.14 | 1.33 | 1.13 | 1.06 | |
Interest coverage | 46.82 | -13.47 | 28.52 | -39.02 | -11.54 | |
Income quality | 1.9 | 2.84 | 1.45 | 2.09 | -0.57 | |
Dividend Yield | 0.12 | 0.09 | 0.07 | 0.09 | 0 | |
Payout ratio | 1.22 | 2.06 | 0.54 | -0.38 | -0.1 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.28 | -1.1 | -0.82 | 0.38 | -2 | |
Capex to revenue | -0.02 | -0.03 | -0.04 | -0.04 | -0.02 | |
Capex to depreciation | -0.78 | -1.01 | -1.64 | -1.56 | -0.94 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.56 | 1.88 | 3.41 | 3.79 | 0 | |
ROIC | 0.07 | -0.04 | 0.06 | -0.11 | -0.05 | |
Return on tangible assets | 0.05 | 0.01 | 0.04 | -0.07 | -0.04 | |
Graham Net | 0.28 | -0.02 | 0.09 | -0.34 | 0 | |
Working capital | 6.83B | 2.07B | 5.14B | 1.77B | 882.22M | |
Tangible asset value | 29.66B | 28.92B | 29.98B | 25.98B | 24.59B | |
Net current asset value | 6.81B | 2.02B | 4.39B | 984.53M | 739.5M | |
Invested capital | 0.05 | 0.16 | 0.07 | 0.09 | 0.15 | |
Average receivables | 2.09B | 1.47B | 1.28B | 2.61B | 2.97B | |
Average payables | 2.53B | 1.72B | 2.19B | 3.01B | 5.38B | |
Average inventory | 7.44B | 5.32B | 4.91B | 6.61B | 7.52B | |
Days sales outstanding | 7.1 | 7.25 | 6.43 | 19.46 | 8.12 | |
Days payables outstanding | 9.04 | 7.63 | 15.21 | 14.01 | 36.11 | |
Days of inventory on hand | 28.51 | 22.93 | 29.1 | 34.91 | 35.74 | |
Receivables turnover | 51.41 | 50.31 | 56.75 | 18.76 | 44.93 | |
Payables turnover | 40.36 | 47.83 | 24 | 26.06 | 10.11 | |
Inventory turnover | 12.8 | 15.92 | 12.54 | 10.46 | 10.21 | |
ROE | 0.07 | 0.02 | 0.07 | -0.11 | -0.06 | |
Capex per share | -0.13 | -0.17 | -0.3 | -0.26 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.38 | 2.02 | 2.15 | 2.94 | 0 | |
Net income per share | -0.08 | -0.02 | -0.08 | 0.03 | 0 | |
Operating cash flow per share | -0.25 | 0 | -0.02 | -0.06 | 0 | |
Free cash flow per share | -0.34 | -0.04 | -0.04 | -0.09 | 0 | |
Cash per share | 0.42 | 0.67 | 0.68 | 0.61 | 0 | |
Book value per share | 2.43 | 2.4 | 2.37 | 2.41 | 0 | |
Tangible book value per share | 2.41 | 2.38 | 2.35 | 2.39 | 0 | |
Share holders equity per share | 2.43 | 2.4 | 2.37 | 2.41 | 0 | |
Interest debt per share | 0.21 | 0.53 | 0.54 | 0.53 | 0 | |
Market cap | 12.59B | 13.03B | 12.11B | 10.98B | 0 | |
Enterprise value | 13.97B | 11.51B | 13.26B | 10.2B | -1.9B | |
P/E ratio | -3.73 | -19.96 | -3.67 | 10.21 | 0 | |
Price to sales ratio | 0.85 | 0.59 | 0.53 | 0.35 | 0 | |
POCF ratio | -4.62 | -441.89 | -61.35 | -18.06 | 0 | |
PFCF ratio | -3.44 | -29.77 | -25.65 | -11.47 | 0 | |
P/B Ratio | 0.48 | 0.5 | 0.48 | 0.43 | 0 | |
PTB ratio | 0.48 | 0.5 | 0.48 | 0.43 | 0 | |
EV to sales | 0.94 | 0.52 | 0.58 | 0.33 | -0.08 | |
Enterprise value over EBITDA | -8.9 | -192.34 | -14.63 | 8.82 | 2.02 | |
EV to operating cash flow | -5.13 | -390.46 | -67.18 | -16.78 | -1.12 | |
EV to free cash flow | -3.81 | -26.31 | -28.09 | -10.66 | -1.69 | |
Earnings yield | -0.07 | -0.01 | -0.07 | 0.02 | 0 | |
Free cash flow yield | -0.29 | -0.03 | -0.04 | -0.09 | 0 | |
Debt to equity | 0.09 | 0.22 | 0.23 | 0.22 | 0.15 | |
Debt to assets | 0.06 | 0.14 | 0.14 | 0.14 | 0.09 | |
Net debt to EBITDA | -0.88 | 25.34 | -1.27 | -0.67 | 2.02 | |
Current ratio | 1.13 | 1.16 | 1.1 | 1.16 | 1.06 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 3.13 | 0.18 | 0.24 | -2.26 | 0 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.12 | -0.18 | -0.04 | 0.15 | -0.06 | |
Sales general and administrative to revenue | -0.11 | 0.02 | -0.02 | 0.02 | -0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0.34 | 13.84 | 1.39 | 0.57 | -0.34 | |
Capex to revenue | -0.06 | -0.02 | -0.01 | -0.01 | -0.02 | |
Capex to depreciation | -0.61 | 0 | -0.33 | 0.42 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.07 | 0.9 | 2.03 | 1.17 | 0 | |
ROIC | -0.04 | 0 | -0.03 | 0.01 | -0.02 | |
Return on tangible assets | -0.02 | 0 | -0.02 | 0.01 | -0.02 | |
Graham Net | -0.34 | -0.26 | -0.34 | -0.19 | 0 | |
Working capital | 1.77B | 2.23B | 1.57B | 2.15B | 882.22M | |
Tangible asset value | 25.98B | 25.86B | 25.06B | 25.33B | 24.59B | |
Net current asset value | 984.53M | 1.35B | 790.52M | 1.98B | 739.5M | |
Invested capital | 0.09 | 0.22 | 0.23 | 0.22 | 0.15 | |
Average receivables | 3.14B | 2.99B | 2.09B | 2.57B | 2.58B | |
Average payables | 4.66B | 4.16B | 3.38B | 2.43B | 5.66B | |
Average inventory | 7.38B | 6.39B | 6.58B | 6.72B | 6.76B | |
Days sales outstanding | 23.43 | 8.65 | 8.08 | 8.9 | 8.05 | |
Days payables outstanding | 10.54 | 26.09 | 6.16 | 16.39 | 34.89 | |
Days of inventory on hand | 26.26 | 26.55 | 34.58 | 27.07 | 34.53 | |
Receivables turnover | 3.84 | 10.4 | 11.14 | 10.11 | 11.19 | |
Payables turnover | 8.54 | 3.45 | 14.62 | 5.49 | 2.58 | |
Inventory turnover | 3.43 | 3.39 | 2.6 | 3.32 | 2.61 | |
ROE | -0.03 | -0.01 | -0.03 | 0.01 | -0.03 | |
Capex per share | -0.09 | -0.04 | -0.03 | -0.03 | 0 |
0338.HK Frequently Asked Questions
What is Sinopec Shanghai Petrochemical Company Limited stock symbol ?
Sinopec Shanghai Petrochemical Company Limited is a CN stock and trading under the symbol 0338.HK
What is Sinopec Shanghai Petrochemical Company Limited stock quote today ?
Sinopec Shanghai Petrochemical Company Limited stock price is $1.05 today.
Is Sinopec Shanghai Petrochemical Company Limited stock public?
Yes, Sinopec Shanghai Petrochemical Company Limited is a publicly traded company.